Specific Aim #1: To determine if levels of CoQ10 are low post-cardiac arrest (CA). We will
perform a prospective trial with the primary endpoint of describing the prevalence of low
serum CoQ10 levels.
Specific Aim #2: To determine if CoQ10 levels in post-CA patients can be increased with the
administration of exogenous CoQ10.. We will perform a randomized control trial (RCT) of
post-CA patients with the secondary endpoint of comparing CoQ10 levels among those randomized
to CoQ10 supplementation vs placebo.